Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

JAK-inhibitors are effective for treating psoriasis and show promise for other skin diseases.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

JAK inhibitors offer new hope for treating severe alopecia areata.

YWS1903 is safe for pregnant rats at moderate doses but causes fetal issues at high doses.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

YAP1 is important for skin regeneration and may affect skin disorder treatments.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.